UNLABELLED: Abstract Background: Lipoprotein particle sizes and concentrations are characteristically altered in patients with insulin resistance (IR) or type 2 diabetes mellitus (T2DM). This study assessed the ability of an IR score, based on nuclear magnetic resonance (NMR)-derived lipoprotein information, to detect IR in otherwise healthy individuals. METHODS: Lipoprotein subclass and size information were evaluated for strength of association with IR, as measured by homeostasis model assessment of insulin resistance (HOMA-IR) in the Multi-Ethnic Study of Atherosclerosis (MESA). To increase the likelihood of identifying subjects with IR, six lipoprotein measures were combined into a single algorithm. The resulting assay [Lipoprotein Insulin Resistance Index (LP-IR)] was developed using HOMA-IR in 4972 nondiabetic subjects from MESA and verified independently using glucose disposal rates (GDRs) measured during hyperinsulinemic-euglycemic clamps in 56 insulin-sensitive, 46 insulin-resistant, and 46 untreated subjects with T2DM. RESULTS: LP-IR exhibited stronger associations with HOMA-IR (r=0.51) and GDR (r=-0.53) than each of the individual lipoprotein parameters as well as the triglycerides/high-density lipoprotein cholesterol (TGs/HDL-C) ratio (r=0.41 and -0.44, respectively). In MESA, associations between the LP-IR score and HOMA-IR were strong in men (r=0.51), women (r=0.52), European Americans (r=0.58), African Americans (r=0.48), Chinese Americans (r=0.49), and Hispanic Americans (r=0.45). When LP-IR was categorized by HOMA-IR and either body mass index (BMI) or fasting plasma glucose (FPG), subgroups were revealed whose LP-IR scores were high (≥ 50), despite having normal BMIs (<24 kg/m(2)) or FPG (<100 mg/dL). CONCLUSIONS: LP-IR scores had strong associations with multiple measures, HOMA-IR, and GDR, the former being more reflective of hepatic and the latter of peripheral insulin sensitivity, and may represent a simple means to identify individuals with IR.
UNLABELLED: Abstract Background: Lipoprotein particle sizes and concentrations are characteristically altered in patients with insulin resistance (IR) or type 2 diabetes mellitus (T2DM). This study assessed the ability of an IR score, based on nuclear magnetic resonance (NMR)-derived lipoprotein information, to detect IR in otherwise healthy individuals. METHODS: Lipoprotein subclass and size information were evaluated for strength of association with IR, as measured by homeostasis model assessment of insulin resistance (HOMA-IR) in the Multi-Ethnic Study of Atherosclerosis (MESA). To increase the likelihood of identifying subjects with IR, six lipoprotein measures were combined into a single algorithm. The resulting assay [Lipoprotein Insulin Resistance Index (LP-IR)] was developed using HOMA-IR in 4972 nondiabetic subjects from MESA and verified independently using glucose disposal rates (GDRs) measured during hyperinsulinemic-euglycemic clamps in 56 insulin-sensitive, 46 insulin-resistant, and 46 untreated subjects with T2DM. RESULTS:LP-IR exhibited stronger associations with HOMA-IR (r=0.51) and GDR (r=-0.53) than each of the individual lipoprotein parameters as well as the triglycerides/high-density lipoprotein cholesterol (TGs/HDL-C) ratio (r=0.41 and -0.44, respectively). In MESA, associations between the LP-IR score and HOMA-IR were strong in men (r=0.51), women (r=0.52), European Americans (r=0.58), African Americans (r=0.48), Chinese Americans (r=0.49), and Hispanic Americans (r=0.45). When LP-IR was categorized by HOMA-IR and either body mass index (BMI) or fasting plasma glucose (FPG), subgroups were revealed whose LP-IR scores were high (≥ 50), despite having normal BMIs (<24 kg/m(2)) or FPG (<100 mg/dL). CONCLUSIONS:LP-IR scores had strong associations with multiple measures, HOMA-IR, and GDR, the former being more reflective of hepatic and the latter of peripheral insulin sensitivity, and may represent a simple means to identify individuals with IR.
Authors: Alan J Garber; Martin J Abrahamson; Joshua I Barzilay; Lawrence Blonde; Zachary T Bloomgarden; Michael A Bush; Samuel Dagogo-Jack; Michael B Davidson; Daniel Einhorn; W Timothy Garvey; George Grunberger; Yehuda Handelsman; Irl B Hirsch; Paul S Jellinger; Janet B McGill; Jeffrey I Mechanick; Paul D Rosenblit; Guillermo E Umpierrez; Michael H Davidson Journal: Endocr Pract Date: 2013 May-Jun Impact factor: 3.443
Authors: Veeradej Pisprasert; Katherine H Ingram; Maria F Lopez-Davila; A Julian Munoz; W Timothy Garvey Journal: Diabetes Care Date: 2012-12-06 Impact factor: 19.112
Authors: Paulo H N Harada; Olga V Demler; Sagar B Dugani; Akintunde O Akinkuolie; Manickavasagar V Moorthy; Paul M Ridker; Nancy R Cook; Aruna D Pradhan; Samia Mora Journal: J Clin Lipidol Date: 2017-06-21 Impact factor: 4.766
Authors: Sagar B Dugani; Akintunde O Akinkuolie; Nina Paynter; Robert J Glynn; Paul M Ridker; Samia Mora Journal: JAMA Cardiol Date: 2016-05-01 Impact factor: 14.676
Authors: Sara Fernández-Castillejo; Rosa-Maria Valls; Olga Castañer; Laura Rubió; Úrsula Catalán; Anna Pedret; Alba Macià; Maureen L Sampson; María-Isabel Covas; Montserrat Fitó; Maria-José Motilva; Alan T Remaley; Rosa Solà Journal: Mol Nutr Food Res Date: 2016-05-06 Impact factor: 5.914
Authors: Ruina Zhang; BingXue Lin; Manish Parikh; Edward A Fisher; Jeffrey S Berger; Jose O Aleman; Sean P Heffron Journal: Surg Obes Relat Dis Date: 2020-05-22 Impact factor: 4.734
Authors: Mohamad M Osman; Linda M Huynh; Farouk M El-Khatib; Maxwell Towe; Huang-Wei Su; Robert Andrianne; Gregory Barton; Gregory Broderick; Arthur L Burnett; Jeffrey D Campbell; Jonathan Clavell-Hernandez; Jessica Connor; Martin Gross; Ross Guillum; Amy I Guise; Georgios Hatzichristodoulou; Gerard D Henry; Tung-Chin Hsieh; Lawrence C Jenkins; Christopher Koprowski; Kook B Lee; Aaron Lentz; Ricardo M Munarriz; Daniar Osmonov; Shu Pan; Kevin Parikh; Sung Hun Park; Amir S Patel; Paul Perito; Hossein Sadeghi-Nejad; Maxime Sempels; Jay Simhan; Run Wang; Faysal A Yafi Journal: Int J Impot Res Date: 2020-03-20 Impact factor: 2.896
Authors: Sara Sokooti; Jose L Flores-Guerrero; Lyanne M Kieneker; Hiddo J L Heerspink; Margery A Connelly; Stephan J L Bakker; Robin P F Dullaart Journal: J Clin Endocrinol Metab Date: 2021-05-13 Impact factor: 5.958